Copyright (c) 2013 AJC
This work is licensed under a Creative Commons Attribution 4.0 International License.
Estimation of Betamethasone in Pharmaceutical Dosage Forms by Visible Spectrophotometry
Corresponding Author(s) : C. Rambabu
Asian Journal of Chemistry,
Vol. 25 No. 4 (2013): Vol 25 Issue 4
Abstract
Simple, accurate, precise and reproducible methods have been developed and validated for the estimation of betamethasone in pharmaceutical dosage forms by visible spectrophotometry. Method-A is based on the reduction of molybdate in acidic medium by betamethasone, producing one or two more of the possible reduced species which have a characteristic intense blue colour (molybdenum blue) chromogen exhibiting lmax at 670 nm. Method-B is based on the oxidation of a-ketol portion of betamethasone to formaldehyde and then converted into its phenyl hyrdazone and then a red colour is developed under the action of oxidizing agent [hexacyano ferrate(III)] in acid medium exhibiting lmax at 520 nm. The results of analysis have been validated statistically and recovery studies confirm the accuracy of the proposed methods. The methods proposed are applied to various pharmaceutical dosage forms as well.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Merck Index, edn. 13, p. 1183, 200.
- A.S. Amin and Y.M. Issa, Anal. Lett., 30, 69 (1997).
- B.Z. Awen, N.T. Hwisa, C.B. Rao, N. Sreekanth and K. Prakash, Int. J. Pharm. Biomed. Res., 1, 87 (2010).
- S. Wiedersberg, A. Naik, C.S. Leopold and R.H. Guy, Br. J. Dermatol., 160, 676 (2009).
- L. Gonzalez, G. Yuln and M.G. Volonte, J. Pharm. Biomed. Anal., 20, 487 (1997).
- C.S. Tamavakopoulos, J.M. Neugebauer, M. Donnelly and P.R. Griffin, J. Chromatogr. B, 776, 161 (2002).
- R.L. Taylor, K.S. Grebe and R.J. Singh, Clin. Chem., 50, 2345 (2002).
- J.E. Kountourellis, C.K. Markopoulou, K.O. Ebete and J.A. Stratis, J. Liq. Chromatogr. Rel. Technol., 18, 3507 (1995).
- L.H. Song, J.G. Bai and W.H. Zhou, Chromatographia, 68, 287 (2008).
- D. Pena-Garcia-Brioles, R. Gonzalo-Lumbreras, R. Izquierdo-Hornillos and A. Santos-Montes, J. Pharm. Biomed. Anal., 36, 65 (2004).
- A.D.S. Pereira, L.S.O.B. Oliveira, G.D. Mendes, J.J. Gabbai and G. Denucei, J. Chromatogr. B, 828, 27 (2005).
- T.T. Qu, R. Zhang, B.J. Wang, X.Y. Liu, G.Y. Yuan and R.C. Guo, Yaoxue Xuebao, 43, 402 (2008).
- J.J. Zou, L. Dai, L. Ding, D.W. Xiao, Z.Y. Bin, H.W. Fan, L. Liu and G.J. Wang, J. Chromatogr. B, 873, 159 (2008).
- P. Deng, X.Y. Chen, X.J. Dai and S.M. Li, Acad J. Second Military Med Univ., 29, 326 (2008).
References
Merck Index, edn. 13, p. 1183, 200.
A.S. Amin and Y.M. Issa, Anal. Lett., 30, 69 (1997).
B.Z. Awen, N.T. Hwisa, C.B. Rao, N. Sreekanth and K. Prakash, Int. J. Pharm. Biomed. Res., 1, 87 (2010).
S. Wiedersberg, A. Naik, C.S. Leopold and R.H. Guy, Br. J. Dermatol., 160, 676 (2009).
L. Gonzalez, G. Yuln and M.G. Volonte, J. Pharm. Biomed. Anal., 20, 487 (1997).
C.S. Tamavakopoulos, J.M. Neugebauer, M. Donnelly and P.R. Griffin, J. Chromatogr. B, 776, 161 (2002).
R.L. Taylor, K.S. Grebe and R.J. Singh, Clin. Chem., 50, 2345 (2002).
J.E. Kountourellis, C.K. Markopoulou, K.O. Ebete and J.A. Stratis, J. Liq. Chromatogr. Rel. Technol., 18, 3507 (1995).
L.H. Song, J.G. Bai and W.H. Zhou, Chromatographia, 68, 287 (2008).
D. Pena-Garcia-Brioles, R. Gonzalo-Lumbreras, R. Izquierdo-Hornillos and A. Santos-Montes, J. Pharm. Biomed. Anal., 36, 65 (2004).
A.D.S. Pereira, L.S.O.B. Oliveira, G.D. Mendes, J.J. Gabbai and G. Denucei, J. Chromatogr. B, 828, 27 (2005).
T.T. Qu, R. Zhang, B.J. Wang, X.Y. Liu, G.Y. Yuan and R.C. Guo, Yaoxue Xuebao, 43, 402 (2008).
J.J. Zou, L. Dai, L. Ding, D.W. Xiao, Z.Y. Bin, H.W. Fan, L. Liu and G.J. Wang, J. Chromatogr. B, 873, 159 (2008).
P. Deng, X.Y. Chen, X.J. Dai and S.M. Li, Acad J. Second Military Med Univ., 29, 326 (2008).